These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18553094)

  • 21. NTproBNP: an important biomarker in cardiac diseases.
    Panagopoulou V; Deftereos S; Kossyvakis C; Raisakis K; Giannopoulos G; Bouras G; Pyrgakis V; Cleman MW
    Curr Top Med Chem; 2013; 13(2):82-94. PubMed ID: 23470072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
    Nguyen K; Fan W; Bertoni A; Budoff MJ; Defilippi C; Lombardo D; Maisel A; Szklo M; Wong ND
    Am J Cardiol; 2020 Apr; 125(8):1194-1201. PubMed ID: 32106929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal function, N-terminal Pro-B-Type natriuretic peptide, propeptide big-endothelin and patients with heart failure and preserved ejection fraction.
    Gergei I; Krämer BK; Scharnagl H; Stojakovic T; März W
    Peptides; 2019 Jan; 111():112-117. PubMed ID: 29684593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery bypass graft surgery.
    Holm J; Vidlund M; Vanky F; Friberg Ö; Håkanson E; Walther S; Svedjeholm R
    Br J Anaesth; 2014 Jul; 113(1):75-82. PubMed ID: 24727704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac troponins and NT-proBNP in the forensic setting: Overview of sampling site, postmortem interval, cardiopulmonary resuscitation, and review of the literature.
    Palmiere C; Tettamanti C; Bonsignore A; De Stefano F; Vanhaebost J; Rousseau G; Scarpelli MP; Bardy D
    Forensic Sci Int; 2018 Jan; 282():211-218. PubMed ID: 29227899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay.
    Zaninotto M; Mion MM; Di Serio F; Caputo M; Ottomano C; Plebani M
    Clin Chem Lab Med; 2010 Jul; 48(7):1029-34. PubMed ID: 20406130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NT-proBNP for prognostic and diagnostic evaluation in patients with acute coronary syndromes.
    Zdravkovic V; Mladenovic V; Colic M; Bankovic D; Lazic Z; Petrovic M; Simic I; Knezevic S; Pantovic S; Djukic A; Zdravkovic N
    Kardiol Pol; 2013; 71(5):472-9. PubMed ID: 23788087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of NT-proBNP and parameters of mental health in depressed coronary artery disease patients.
    Fangauf SV; Herbeck Belnap B; Meyer T; Albus C; Binder L; Deter HC; Ladwig KH; Michal M; Ronel J; Rothenberger A; Söllner W; Wachter R; Weber CS; Herrmann-Lingen C;
    Psychoneuroendocrinology; 2018 Oct; 96():188-194. PubMed ID: 29982099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis.
    Savarese G; Musella F; D'Amore C; Vassallo E; Losco T; Gambardella F; Cecere M; Petraglia L; Pagano G; Fimiani L; Rengo G; Leosco D; Trimarco B; Perrone-Filardi P
    JACC Heart Fail; 2014 Apr; 2(2):148-58. PubMed ID: 24720923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
    Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
    Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G; Runkel S; Zdunek D; Hitzler WE
    Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.
    Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH
    J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiopoietin-2 provides no incremental predictive value for the presence of obstructive coronary artery disease over N-terminal pro-brain natriuretic peptide.
    Jian W; Mo CH; Yang GL; Li L; Gui C
    J Clin Lab Anal; 2019 Oct; 33(8):e22972. PubMed ID: 31257664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
    Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
    Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis.
    Etgen T; Baum H; Sander K; Sander D
    Stroke; 2005 Feb; 36(2):270-5. PubMed ID: 15604421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NT-proBNP is superior to BNP for predicting first cardiovascular events in the general population: the Heinz Nixdorf Recall Study.
    Kara K; Lehmann N; Neumann T; Kälsch H; Möhlenkamp S; Dykun I; Broecker-Preuss M; Pundt N; Moebus S; Jöckel KH; Erbel R; Mahabadi AA
    Int J Cardiol; 2015 Mar; 183():155-61. PubMed ID: 25666125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-terminal pro-B-type natriuretic Peptide predicts significant coronary artery lesion in the unstable angina patients with normal electrocardiogram, echocardiogram, and cardiac enzymes.
    Hong SN; Yoon NS; Ahn Y; Lim SY; Kim YS; Yun KH; Kang DK; Lee SH; Lee YS; Kim KH; Son IS; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Circ J; 2005 Dec; 69(12):1472-6. PubMed ID: 16308494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The predictive value of plasma N-terminal pro-B-type natriuretic peptide levels in the evaluation of prognosis and the severity of patients with septic shock induced myocardial suppression].
    Chen W; Zhao L; Liu P; Sheng B; Zhen J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Jan; 25(1):40-4. PubMed ID: 23611096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration.
    Bargnoux AS; Klouche K; Fareh J; Barazer I; Villard-Saussine S; Dupuy AM; Leray-Moragues H; Giuliani I; Canaud B; Cristol JP
    Clin Chem Lab Med; 2008; 46(7):1019-24. PubMed ID: 18624622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.